Filing Flows › Health Care › Chemed (CHE)
Chemed (CHE) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Oct 29, 2026 · Chemed (CHE) Q3 2026 earnings results →
Q3 2026 Revenue up 11% year over year to $691M · 10¢ of every $1 of revenue kept as net profit · operating margin 14.0%
Chemed made $691M in Q3 2026 (+11% Y/Y): VITAS $457M, Roto-Rooter $234M. Operating margin 14.0%, net earnings $71.6M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Oct 29, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $690.9M in Q3 2026, up 11% year over year and up 3% from the previous quarter. VITAS was the largest line at 66% of revenue. VITAS added $49.7M year over year (up 12%), 75% of the total change.
Operating profit was $96.4M, a 14.0% margin (up 2.0 points year over year). Of the extra revenue versus Q3 2025, 33% reached operating profit, above the 12% margin then. Total costs grew 8% against revenue growth of 11%. The fastest-growing cost line was Other operating costs (+30%). Net earnings were $71.6M, up 12% year over year. The effective tax rate was 25.9%.
Operating cash flow was $56.6M (down 32% year over year), 79% of net earnings. Non-cash charges added back $17.4M of depreciation and amortization. Working capital and other items used $32.5M. Capital expenditures of $18.7M left free cash flow of $37.9M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Oct 29, 2026 | $691M | +11% | 14.0% | $71.6M | $56.6M |
| Q2 2026 | 10-Q | Jul 31, 2026 | $673M | +9% | 13.2% | $67.7M | $84.8M |
| Q1 2026 | 10-Q | Apr 28, 2026 | $658M | +2% | 12.9% | $66.3M | $88.2M |
| Q4 2025 | 10-K | Feb 27, 2026 | $639M | -0.1% | 15.7% | $76.8M | $134M |
| Q3 2025 | 10-Q | Oct 31, 2025 | $625M | +3% | 12.0% | $64.2M | $83.4M |
| Q2 2025 | 10-Q | Jul 31, 2025 | $619M | +4% | 11.0% | $52.5M | $139M |
| Q1 2025 | 10-Q | Apr 28, 2025 | $647M | +10% | 14.6% | $71.8M | $32.7M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Sells to
- Medicare & Medicaid — 3% of its revenue · Stated in 10-K (sentence) · source
About Chemed
Chemed Corporation (the “Company” or “Chemed”) was incorporated in Delaware in 1970 as a subsidiary of W.R. Grace & Co. and succeeded to the business of W.R. Grace & Co.’s Special Products Group as of April 30, 1971 and remained a subsidiary of W.R. Grace & Co. until March 10, 1982. Chemed purchases, operates and divests subsidiaries engaged in diverse business activities for the purposes of maximizing shareholder value. The Company’s day to day operating businesses are managed on a decentralized basis. There are few integrated business functions between the operating units and Chemed (such as sales, marketing or purchasing).
In its own words, from its 10-K, filed Feb 27, 2026.
Chemed against its Services-Home Health Care Services peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +11% against the peers' median +11%. Operating margin: 14.0% against the peers' median 10.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| CHE Chemed | Q3 2026 | $691M | +11% | 14.0% |
| BTSG BrightSpring Health Services | Q3 2026 | $4.2B | +26% | 3.8% |
| OPCH Option Care Health | Q3 2026 | $1.5B | +4% | 6.0% |
| AHCO AdaptHealth | Q3 2026 | $746M | +11% | -20.9% |
| AVAH Aveanna Healthcare Holdings | Q2 2026 | $670M | +14% | 11.9% |
| ADUS Addus HomeCare | Q3 2026 | $388M | +7% | 10.3% |
Source: Chemed 10-Q on SEC EDGAR · CIK 19584 · Services-Home Health Care Services
13F: who owns CHE and who is buying
More on CHE
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results